Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2001-07-09 (24 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VAILHAUQUES (34570), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EURL PHARMACIE GAL : revenue, balance sheet and financial ratios
EURL PHARMACIE GAL is a French company
founded 24 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VAILHAUQUES (34570),
this company of category PME
shows in 2020 a net income positive of 163 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EURL PHARMACIE GAL (SIREN 438598567)
Indicator
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
162 602 €
144 076 €
128 002 €
145 278 €
153 755 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2020, EURL PHARMACIE GAL generates positive net income of 163 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 154 k€ -> 163 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
162 602 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 361%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
360.594%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
17.001%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
Debt ratio
371.696
449.383
493.166
424.313
360.594
Financial autonomy
17.348
14.89
13.239
15.124
17.001
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
360.592020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average
In 2020, the debt ratio of EURL PHARMACIE GAL (360.59) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
17.0%2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Watch
In 2020, the financial autonomy of EURL PHARMACIE GAL (17.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 83.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
83.581
Liquidity indicators evolution EURL PHARMACIE GAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
Liquidity ratio
89.58
89.438
82.811
88.323
83.581
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
83.582020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Watch
In 2020, the liquidity ratio of EURL PHARMACIE GAL (83.58) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of EURL PHARMACIE GAL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of EURL PHARMACIE GAL is estimated at
2 297 998 €
(range 1 532 273€ - 3 100 620€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
1532k€2297k€3100k€
2 297 998 €Range: 1 532 273€ - 3 100 620€
NAF 5 année 2020
Valuation method used
Net Income Multiple
162 602 €
×
14.1x
=2 297 999 €
Range: 1 532 273€ - 3 100 620€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare EURL PHARMACIE GAL with other companies in the same sector:
Frequently asked questions about EURL PHARMACIE GAL
What is the revenue of EURL PHARMACIE GAL ?
The revenue of EURL PHARMACIE GAL is not publicly disclosed (confidential accounts filed with INPI).
Is EURL PHARMACIE GAL profitable?
Yes, EURL PHARMACIE GAL generated a net profit of 163 k€ in 2020.
Where is the headquarters of EURL PHARMACIE GAL ?
The headquarters of EURL PHARMACIE GAL is located in VAILHAUQUES (34570), in the department Herault.
Where to find the tax return of EURL PHARMACIE GAL ?
The tax return of EURL PHARMACIE GAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EURL PHARMACIE GAL operate?
EURL PHARMACIE GAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart